These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 495324)

  • 1. Preparation of intrinsically-labelled kinins.
    Chung A; Ryan JW; Berryer P
    Adv Exp Med Biol; 1979; 120A():39-50. PubMed ID: 495324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin.
    Oliveira EB; Martins AR; Camargo AC
    Biochemistry; 1976 May; 15(9):1967-74. PubMed ID: 5120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
    Liebmann C; Bossé R; Escher E
    Mol Pharmacol; 1994 Nov; 46(5):949-56. PubMed ID: 7969085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinin analogs containing alpha-aminoisobutyric acid (Aib).
    Vavrek RJ; Stewart JM
    Peptides; 1980; 1(3):231-5. PubMed ID: 7232227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity studies on bradykinin and related peptides: agonists.
    Rhaleb NE; Drapeau G; Dion S; Jukic D; Rouissi N; Regoli D
    Br J Pharmacol; 1990 Mar; 99(3):445-8. PubMed ID: 2158842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.
    DelBel EA; Padovan AP; Padovan GJ; Sellinger OZ; Martins AR
    Cell Mol Neurobiol; 1989 Sep; 9(3):379-400. PubMed ID: 2558804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activities of new side chain and backbone cyclic bradykinin analogues.
    Schumann C; Seyfarth L; Greiner G; Paegelow I; Reissmann S
    J Pept Res; 2002 Aug; 60(2):128-40. PubMed ID: 12102726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive action of bradykinin and related kinins of larger molecular weights by the intraventricular route.
    Ribeiro SA; Silva MR
    Br J Pharmacol; 1973 Mar; 47(3):517-28. PubMed ID: 4730829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
    Drapeau G; deBlois D; Marceau F
    J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.
    Cheronis JC; Whalley ET; Nguyen KT; Eubanks SR; Allen LG; Duggan MJ; Loy SD; Bonham KA; Blodgett JK
    J Med Chem; 1992 May; 35(9):1563-72. PubMed ID: 1578482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.
    Cheronis JC; Whalley ET; Blodgett JK
    Agents Actions Suppl; 1992; 38 ( Pt 1)():551-8. PubMed ID: 1466296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist activity at the kinin B1 receptor: structural requirements of the central tetrapeptide.
    Rovero P; Pellegrini M; Di Fenza A; Meini S; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mierke DF
    J Med Chem; 2001 Jan; 44(2):274-8. PubMed ID: 11170638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus.
    Ballet S; De Wachter R; Van Rompaey K; Tömböly C; Feytens D; Töth G; Quartara L; Cucchi P; Meini S; Tourwé D
    J Pept Sci; 2007 Mar; 13(3):164-70. PubMed ID: 17266049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of kinin antagonists.
    Lembeck F; Griesbacher T
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S75-7. PubMed ID: 1697366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptides.
    Claeson G; Fareed J; Larsson C; Kindel G; Arielly S; Simonsson R; Messmore HL; Balis JU
    Adv Exp Med Biol; 1979; 120B():691-713. PubMed ID: 517262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth muscle selectivity in bradykinin analogs with multiple D-amino acid substitutions.
    Vavrek RJ; Stewart JM
    Adv Exp Med Biol; 1986; 198 Pt A():543-7. PubMed ID: 3812092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of peptides by the solid-phase method. III. Bradykinin: fragments and analogs.
    Park WK; St-Pierre SA; Barabé J; Regoli D
    Can J Biochem; 1978 Feb; 56(2):92-100. PubMed ID: 630458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endopeptidases (kininases) are able to hydrolyze kinins in tubular fluid along the rat nephron.
    Casarini DE; Boim MA; Stella RC; Schor N
    Am J Physiol; 1999 Jul; 277(1):F66-74. PubMed ID: 10409299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New bradykinin B(2) receptor antagonists - influence of C-terminal segment modifications on their pharmacological properties.
    Sleszyńska M; Kwiatkowska A; Sobolewski D; Wierzba TH; Katarzyńska J; Zabrocki J; Borovickova L; Slaninová J; Prahl A
    Acta Biochim Pol; 2009; 56(4):641-8. PubMed ID: 19997652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of bradykinin and its metabolites by rat brain synaptic membranes.
    Orawski AT; Simmons WH
    Peptides; 1989; 10(5):1063-73. PubMed ID: 2608554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.